Comparing 3D/2D electrical impedance tomography and the R/I ratio to measure lung recruitability during mechanical ventilation

Lung Recruitment Assessed by Two-Dimensional/Three-Dimensional Electrical Impedance Tomography and Recruitment-to-Inflation Ratio in Acute Respiratory Failure Patients With Mechanical Ventilation

Observational Peking Union Medical College Hospital · NCT07379242

This test tries to see if two imaging methods (3D and 2D electrical impedance tomography) and a pressure-based recruitment-to-inflation (R/I) ratio give consistent estimates of how much the lungs can be recruited in sedated adults on mechanical ventilation for acute respiratory failure.

Quick facts

Study typeObservational
Enrollment50 (estimated)
Ages18 Years and up
SexAll
SponsorPeking Union Medical College Hospital Academic / other
Locations1 site (Beijing, Beijing Municipality)
Trial IDNCT07379242 on ClinicalTrials.gov

What this trial studies

This is an observational protocol that compares lung recruitability estimates from 3D-EIT, 2D-EIT, and the recruitment-to-inflation (R/I) ratio in mechanically ventilated adults with acute respiratory failure. Participants undergo a standardized PEEP titration while synchronized EIT monitoring records regional impedance changes and R/I ratios are measured at high and low PEEP levels. The study examines agreement and differences between the techniques rather than testing a therapeutic intervention. Patients with contraindications to EIT, hemodynamic intolerance to high PEEP, or other predefined exclusions are not enrolled.

Who should consider this trial

Good fit: Mechanically ventilated adults with acute respiratory failure who are sedated without spontaneous breathing, have a PaO2/FiO2 (oxygenation index) below 300 mmHg, and whose treating team plans a PEEP titration are ideal candidates.

Not a fit: Patients under 18, pregnant patients, those with contraindications to EIT (for example implanted cardiac devices or chest wounds), or those with hemodynamic instability or high-risk pneumothorax/mediastinal emphysema are unlikely to benefit or be eligible.

Why it matters

Potential benefit: If successful, clinicians could have clearer guidance on which bedside measurement best predicts lung recruitability, helping tailor PEEP settings to improve oxygenation and reduce ventilator-induced lung injury.

How similar studies have performed: Previous work using 2D-EIT and the R/I ratio has shown promise for estimating recruitability, but direct comparisons that include 3D-EIT are limited, so this study builds on existing methods while adding 3D data.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Mechanically ventilated patients under sedation and analgesia with no spontaneous breathing.
* Oxygenation index \< 300 mmHg.
* Patients who are clinically judged by the attending doctor to require the PEEP titration.

Exclusion Criteria:

* Aged under 18 years.
* Pregnancy.
* Contraindications for EIT examination (e.g. automatic implantable cardioverter defibrillator, implantable pumps, chest wounds limiting electrode belt placement, severe thoracic deformity, and others).
* No informed consent obtained.
* Hemodynamic instability with intolerance to high PEEP levels determined by the attending doctor.
* High-risk populations with pneumothorax, mediastinal emphysema, and other such conditions determined by the attending doctor.

Where this trial is running

Beijing, Beijing Municipality

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Acute Respiratory FailureAcute respiratory failurePEEP titration3D-EIT2D-EITLung recruitabilityR/I ratio
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.